Use of transcutaneous bilirubinometers in preterm infants in Japan
Pediatrics International · 2026
DOI: 10.1111/ped.70386 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatrics International, 2026. Verfasst von Yue Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan. Hauptthemen laut MEDLINE: Bilirubin, Jaundice, Neonatal, Neonatal Screening. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare, Ministry of Health.
Themen: Neonatologie
Abstract (Originalsprache)
Background
This study aimed to investigate the current use of transcutaneous bilirubinometers (TcBMs) in preterm infants in Japan, given their potential for noninvasive and prolonged jaundice monitoring.
Methods
A nationwide questionnaire survey was conducted across 229 facilities for preterm infants. Responses were stratified by facility level and analyzed using Fisher's exact test.
Results
Of the 229 facilities, 149 (65%) responded, with 76 (51%) using TcBMs in preterm infants. TcBM use increased with gestational age. TcBMs were more commonly used in Level II facilities than in Level III/IV facilities (63% vs. 40%, p = 0.0087). In late preterm infants, TcBMs tended to be used immediately after birth, whereas in extremely preterm infants, they were often introduced after the first postnatal week. Level II facilities showed a tendency to use TcBMs immediately after birth, even in infants of relatively low gestational age. JM‐105 was the most used device, and the anterior chest was the primary measurement site. 55% of the facilities using TcBMs reported adopting Morioka's new treatment criteria for neonatal jaundice. While most facilities disinfected devices after each use, concerns remained regarding measurement accuracy and infection control.
Conclusion
TcBMs are used in approximately half of the facilities in Japan, with greater use in Level II centers. Broader dissemination of guidelines may encourage safer and more consistent practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan.
- Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
- Department of Neonatology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
- Department of Pediatrics, Division of Neonatal Medicine, Saitama Medical University Hospital, Moroyama-machi, Japan.
- Department of Pediatrics, Kagawa University School of Medicine, Miki-cho, Japan.
- Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
ORCID-Profile: Yoshiaki Sato, Sota Iwatani, Takashi Kusaka, Akihisa Okumura
Förderung
- Ministry of Health, Labour and Welfare
- Ministry of Health
Zitieren
APA
Xu, Y., Sato, Y., Morioka, I., Iwatani, S., Kunikata, T., Kusaka, T., Maruo, Y., Arai, H., & Okumura, A. (2026). Use of transcutaneous bilirubinometers in preterm infants in Japan. Pediatrics International. https://doi.org/10.1111/ped.70386
Vancouver
Xu Y, Sato Y, Morioka I, Iwatani S, Kunikata T, Kusaka T, et al. Use of transcutaneous bilirubinometers in preterm infants in Japan. Pediatrics International. 2026. doi:10.1111/ped.70386
BibTeX
@article{Xu2026,
author = {Xu, Yue and Sato, Yoshiaki and Morioka, Ichiro and Iwatani, Sota and Kunikata, Tetsuya and Kusaka, Takashi and Maruo, Yoshihiro and Arai, Hiroshi and Okumura, Akihisa},
title = {Use of transcutaneous bilirubinometers in preterm infants in Japan},
journal = {Pediatrics International},
year = {2026},
doi = {10.1111/ped.70386}
}
EUVIMED